Skip to main content
logo
Rapid Dose Therapeutics Corp. (RDTCF)
OTCMKTS · Delayed Price · Currency is USD
0.0760
-0.0140 (-15.56%)
At close: Jan 29, 2026

Rapid Dose Therapeutics Revenue

Rapid Dose Therapeutics had revenue of 657.14K CAD in the quarter ending November 30, 2025, with 30.98% growth. This brings the company's revenue in the last twelve months to 2.78M, up 72.84% year-over-year. In the fiscal year ending February 28, 2025, Rapid Dose Therapeutics had annual revenue of 2.09M with 104.34% growth.

Revenue (ttm)
2.78M CAD
Revenue Growth
+72.84%
P/S Ratio
6.72
Revenue / Employee
n/a
Employees
n/a
Market Cap
13.39M USD

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Feb 28, 20252.09M1.06M104.34%
Feb 29, 20241.02M302.13K42.06%
Feb 28, 2023718.30K-1.03M-59.00%
Feb 28, 20221.75M996.72K131.98%
Feb 28, 2021755.20K653.70K644.06%
Feb 29, 2020 Pro Pro Pro
Feb 28, 2019 Pro Pro Pro
Feb 28, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
HOOKIPA Pharma9.35M
Zeo ScientifiX5.20M
TRON Group1.01M
Zenith Capital500.00K
Provectus Biopharmaceuticals350.44K
Revenue Rankings

Rapid Dose Therapeutics News

More News